{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:20:48Z","timestamp":1787736048493,"version":"build-2784847793"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011347","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000}}],"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","award":["AGTRP"],"award-info":[{"award-number":["AGTRP"]}],"id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP180100246"],"award-info":[{"award-number":["DP180100246"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1109035"],"award-info":[{"award-number":["1109035"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>American Samoa underwent seven rounds of mass drug administration (MDA) for lymphatic filariasis (LF) from 2000-2006, but subsequent surveys found evidence of ongoing transmission. American Samoa has since undergone further rounds of MDA in 2018, 2019, and 2021; however, recent surveys indicate that transmission is still ongoing. GEOFIL, a spatially-explicit agent-based LF model, was used to compare the effectiveness of territory-wide triple-drug MDA (3D-MDA) with targeted surveillance and treatment strategies. Both approaches relied on treatment with ivermectin, diethylcarbamazine, and albendazole. We simulated three levels of whole population coverage for 3D-MDA: 65%, 73%, and 85%, while the targeted strategies relied on surveillance in schools, workplaces, and households, followed by targeted treatment. In the household-based strategies, we simulated 1-5 teams travelling village-to-village and offering antigen (Ag) testing to randomly selected households in each village. If an Ag-positive person was identified, treatment was offered to members of all households within 100m-1km of the positive case. All simulated interventions were finished by 2027 and their effectiveness was judged by their \u2018control probability\u2019\u2014the proportion of simulations in which microfilariae prevalence decreased between 2030 and 2035. Without future intervention, we predict Ag prevalence will rebound. With 3D-MDA, a 90% control probability required an estimated \u2265 4 further rounds with 65% coverage, \u2265 3 rounds with 73% coverage, or \u2265 2 rounds with 85% coverage. While household-based strategies were substantially more testing-intensive than 3D-MDA, they could offer comparable control probabilities with substantially fewer treatments; e.g. three teams aiming to test 50% of households and offering treatment to a 500m radius had approximately the same control probability as three rounds of 73% 3D-MDA, but used &lt; 40% the number of treatments. School- and workplace-based interventions proved ineffective. Regardless of strategy, reducing Ag prevalence below the 1% target threshold recommended by the World Health Organization was a poor indicator of the interruption of LF transmission, highlighting the need to review blanket elimination targets.<\/jats:p>","DOI":"10.1371\/journal.pntd.0011347","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:56:24Z","timestamp":1684432584000},"page":"e0011347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-5024","authenticated-orcid":true,"given":"Callum","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"McLure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"issue":"9747","key":"pntd.0011347.ref001","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"MJ Taylor","year":"2010","journal-title":"The Lancet"},{"key":"pntd.0011347.ref002","first-page":"497","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2020","volume":"96","author":"World Health Organization","year":"2021","journal-title":"Weekly Epidemiological Record"},{"issue":"9","key":"pntd.0011347.ref003","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1016\/S2214-109X(20)30286-2","article-title":"The global distribution of lymphatic filariasis, 2000\u201318: a geospatial analysis","volume":"8","author":"EA Cromwell","year":"2020","journal-title":"The Lancet Global Health"},{"issue":"11","key":"pntd.0011347.ref004","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1371\/journal.pntd.0003319","article-title":"Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease","volume":"8","author":"K Ramaiah","year":"2014","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0011347.ref005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: treatment, control and elimination","volume":"61","author":"EA Ottesen","year":"2006","journal-title":"Advances in parasitology"},{"issue":"Supplement_1","key":"pntd.0011347.ref006","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/inthealth\/ihaa046","article-title":"A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery","volume":"13","author":"GJ Weil","year":"2021","journal-title":"International Health"},{"key":"pntd.0011347.ref007","volume-title":"Lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration: A manual for national elimination programmes","author":"Organization WH","year":"2011"},{"issue":"1","key":"pntd.0011347.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-8-22","article-title":"Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis","volume":"8","author":"M Gambhir","year":"2010","journal-title":"BMC biology"},{"issue":"1","key":"pntd.0011347.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-1152-3","article-title":"Modelling strategies to break transmission of lymphatic filariasis-aggregation, adherence and vector competence greatly alter elimination","volume":"8","author":"MA Irvine","year":"2015","journal-title":"Parasites & vectors"},{"issue":"1","key":"pntd.0011347.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1768-y","article-title":"Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators","volume":"9","author":"P Jambulingam","year":"2016","journal-title":"Parasites & vectors"},{"issue":"1871","key":"pntd.0011347.ref011","doi-asserted-by":"crossref","first-page":"20172253","DOI":"10.1098\/rspb.2017.2253","article-title":"Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis","volume":"285","author":"MA Irvine","year":"2018","journal-title":"Proceedings of the Royal Society B: Biological Sciences"},{"key":"pntd.0011347.ref012","unstructured":"World Health Organization. The PacELF way: towards the elimination of lymphatic filariasis from the Pacific, 1999-2005; 2006."},{"issue":"1","key":"pntd.0011347.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-9-92","article-title":"Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries","volume":"9","author":"C Huppatz","year":"2009","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"pntd.0011347.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-017-0075-4","article-title":"Overview of PacELF\u2014the Pacific Programme for the Elimination of Lymphatic Filariasis","volume":"45","author":"K Ichimori","year":"2017","journal-title":"Tropical medicine and health"},{"issue":"Supplement_1","key":"pntd.0011347.ref015","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/inthealth\/ihaa087","article-title":"Progress in the elimination of lymphatic filariasis in the Western Pacific Region: successes and challenges","volume":"13","author":"A Yajima","year":"2021","journal-title":"International Health"},{"issue":"3","key":"pntd.0011347.ref016","doi-asserted-by":"crossref","first-page":"e0006347","DOI":"10.1371\/journal.pntd.0006347","article-title":"Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa","volume":"12","author":"KY Won","year":"2018","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"7","key":"pntd.0011347.ref017","doi-asserted-by":"crossref","first-page":"e0006583","DOI":"10.1371\/journal.pntd.0006583","article-title":"Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance-American Samoa, 2016","volume":"12","author":"M Sheel","year":"2018","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"11","key":"pntd.0011347.ref018","doi-asserted-by":"crossref","first-page":"e0005108","DOI":"10.1371\/journal.pntd.0005108","article-title":"Lymphatic filariasis elimination in American Samoa: evaluation of molecular xenomonitoring as a surveillance tool in the endgame","volume":"10","author":"CL Lau","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"9","key":"pntd.0011347.ref019","doi-asserted-by":"crossref","first-page":"e0005914","DOI":"10.1371\/journal.pntd.0005914","article-title":"Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration","volume":"11","author":"CL Lau","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"21","key":"pntd.0011347.ref020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.15585\/mmwr.mm6921a3","article-title":"Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia\u2014American Samoa, 2019","volume":"69","author":"MA Hast","year":"2020","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"pntd.0011347.ref021","doi-asserted-by":"crossref","first-page":"100591","DOI":"10.1016\/j.epidem.2022.100591","article-title":"Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration","author":"A McLure","year":"2022","journal-title":"Epidemics"},{"key":"pntd.0011347.ref022","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.actatropica.2010.08.021","article-title":"Improving community participation to eliminate lymphatic filariasis in American Samoa","volume":"120","author":"JD King","year":"2011","journal-title":"Acta tropica"},{"issue":"5","key":"pntd.0011347.ref023","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0035-9203(92)90096-U","article-title":"Factors affecting transmission of Wuchereria bancrofti by anopheline mosquitoes. 4. Facilitation, limitation, proportionality and their epidemiological significance","volume":"86","author":"B Southgate","year":"1992","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"pntd.0011347.ref024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/oxfordjournals.aje.a119750","article-title":"Observations on the epidemiology of human filariasis in French Oceania","volume":"61","author":"L Rosin","year":"1955","journal-title":"American Journal of Epidemiology"},{"key":"pntd.0011347.ref025","first-page":"199","article-title":"Relations math\u00e9matiques entre le nombre des microfilaires ing\u00e9r\u00e9es et le nombre des parasites chez diff\u00e9rents vecteurs naturelles ou exp\u00e9rimentaux de filarioses","volume":"12","author":"G Pichon","year":"1974","journal-title":"Cahiers ORSTOM, s\u00e9rie Entomologie m\u00e9dicale et Parasitologie"},{"key":"pntd.0011347.ref026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.ento.54.110807.090626","article-title":"Role of vector control in the global program to eliminate lymphatic filariasis","volume":"54","author":"MJ Bockarie","year":"2009","journal-title":"Annual review of entomology"},{"issue":"3","key":"pntd.0011347.ref027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2915.2006.00629.x","article-title":"Transmission dynamics of lymphatic filariasis: vector-specific density dependence in the development of Wuchereria bancrofti infective larvae in mosquitoes","volume":"20","author":"L Snow","year":"2006","journal-title":"Medical and veterinary entomology"},{"issue":"10","key":"pntd.0011347.ref028","doi-asserted-by":"crossref","first-page":"e0006066","DOI":"10.1371\/journal.pntd.0006066","article-title":"Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka","volume":"11","author":"RU Rao","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"10","key":"pntd.0011347.ref029","doi-asserted-by":"crossref","first-page":"e0005610","DOI":"10.1371\/journal.pntd.0005610","article-title":"Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis","volume":"11","author":"JR Harris","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0011347.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-2-14","article-title":"Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea","volume":"2","author":"ND Alexander","year":"2003","journal-title":"Filaria journal"},{"key":"pntd.0011347.ref031","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.actatropica.2010.12.004","article-title":"First evidence of spatial clustering of lymphatic filariasis in an Aedes polynesiensis endemic area","volume":"120","author":"H Joseph","year":"2011","journal-title":"Acta Tropica"},{"issue":"1","key":"pntd.0011347.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-3-3","article-title":"Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence","volume":"3","author":"CH Washington","year":"2004","journal-title":"Filaria journal"},{"issue":"11","key":"pntd.0011347.ref033","doi-asserted-by":"crossref","first-page":"e1926","DOI":"10.1371\/journal.pntd.0001926","article-title":"Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation","volume":"6","author":"S Swaminathan","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0011347.ref034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-1091-z","article-title":"The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration","volume":"8","author":"DK de Souza","year":"2015","journal-title":"Parasites & vectors"},{"issue":"11","key":"pntd.0011347.ref035","doi-asserted-by":"crossref","first-page":"e3297","DOI":"10.1371\/journal.pntd.0003297","article-title":"Seroprevalence and spatial epidemiology of lymphatic filariasis in American Samoa after successful mass drug administration","volume":"8","author":"CL Lau","year":"2014","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"8","key":"pntd.0011347.ref036","doi-asserted-by":"crossref","first-page":"e2874","DOI":"10.1371\/journal.pone.0002874","article-title":"Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis","volume":"3","author":"M Gambhir","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"pntd.0011347.ref037","doi-asserted-by":"crossref","first-page":"e0008916","DOI":"10.1371\/journal.pntd.0008916","article-title":"Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing \u2018number needed to test\u2019by targeting older age groups, hotspots, and household members of infected persons","volume":"14","author":"CL Lau","year":"2020","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0011347.ref038","first-page":"1","volume-title":"BMC proceedings","author":"EE Macpherson","year":"2015"},{"key":"pntd.0011347.ref039","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.epidem.2018.12.003","article-title":"GEOFIL: A spatially-explicit agent-based modelling framework for predicting the long-term transmission dynamics of lymphatic filariasis in American Samoa","volume":"27","author":"Z Xu","year":"2019","journal-title":"Epidemics"},{"issue":"1","key":"pntd.0011347.ref040","first-page":"1","article-title":"The extensive networks of frequent population mobility in the Samoan Islands and their implications for infectious disease transmission","volume":"8","author":"Z Xu","year":"2018","journal-title":"Scientific reports"},{"issue":"1","key":"pntd.0011347.ref041","first-page":"1","article-title":"A synthetic population for modelling the dynamics of infectious disease transmission in American Samoa","volume":"7","author":"Z Xu","year":"2017","journal-title":"Scientific reports"},{"key":"pntd.0011347.ref042","unstructured":"Organization WH, et al. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. WHO\/HTM\/NTD\/PCT\/2017.07. World Health Organization; 2017."},{"issue":"Supplement_5","key":"pntd.0011347.ref043","first-page":"39","article-title":"The importance of partnership in the rollout of triple-drug therapy to eliminate lymphatic filariasis in the Pacific","volume":"106","author":"M Rainima-Qaniuci","year":"2022","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"pntd.0011347.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-3996-4","article-title":"Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014","volume":"13","author":"PM Graves","year":"2020","journal-title":"Parasites & Vectors"},{"issue":"Supplement_4","key":"pntd.0011347.ref045","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1093\/cid\/ciy003","article-title":"Are alternative strategies required to accelerate the global elimination of lymphatic filariasis? Insights from mathematical models","volume":"66","author":"WA Stolk","year":"2018","journal-title":"Clinical infectious diseases"},{"issue":"9","key":"pntd.0011347.ref046","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/trstmh\/tru057","article-title":"Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review","volume":"108","author":"BV Babu","year":"2014","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"pntd.0011347.ref047","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2015-000021","article-title":"Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage","volume":"1","author":"CM Stone","year":"2016","journal-title":"BMJ Global Health"},{"issue":"1","key":"pntd.0011347.ref048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-017-2206-5","article-title":"The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission","volume":"10","author":"SH Farrell","year":"2017","journal-title":"Parasites & vectors"},{"issue":"9","key":"pntd.0011347.ref049","doi-asserted-by":"crossref","first-page":"e0005934","DOI":"10.1371\/journal.pntd.0005934","article-title":"How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis","volume":"11","author":"RJ Kastner","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"11","key":"pntd.0011347.ref050","doi-asserted-by":"crossref","first-page":"e0008854","DOI":"10.1371\/journal.pntd.0008854","article-title":"A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018","volume":"14","author":"GA Willis","year":"2020","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0011347.ref051","first-page":"69","article-title":"Community-directed treatment of lymphatic filariasis in Kenya and its role in the national programmes for elimination of lymphatic filariasis","volume":"13","author":"N Wamae","year":"2006","journal-title":"African journal of health sciences"},{"issue":"1","key":"pntd.0011347.ref052","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00034983.2001.11813617","article-title":"Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana","volume":"95","author":"M Gyapong","year":"2001","journal-title":"Annals of Tropical Medicine & Parasitology"},{"issue":"11","key":"pntd.0011347.ref053","doi-asserted-by":"crossref","first-page":"e0007861","DOI":"10.1371\/journal.pntd.0007861","article-title":"How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia","volume":"13","author":"A Silumbwe","year":"2019","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"5","key":"pntd.0011347.ref054","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2006.09.002","article-title":"Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka","volume":"101","author":"S Gunawardena","year":"2007","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"Supplement_1","key":"pntd.0011347.ref055","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/inthealth\/ihaa086","article-title":"Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis","volume":"13","author":"A Krentel","year":"2021","journal-title":"International health"},{"issue":"9","key":"pntd.0011347.ref056","doi-asserted-by":"crossref","first-page":"e0004914","DOI":"10.1371\/journal.pntd.0004914","article-title":"The role of nurses and community health workers in confronting neglected tropical diseases in Sub-Saharan Africa: a systematic review","volume":"10","author":"AG Corley","year":"2016","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0011347.ref057","unstructured":"World Health Organization. Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic. World Health Organization and the United Nations Children\u2019s Fund (UNICEF); 2020."},{"issue":"2","key":"pntd.0011347.ref058","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/bjsw\/bcz160","article-title":"Research Capacity Strengthening in American Samoa: Fa\u2019avaeina le Fa\u2019atelega o le Tomai Sa\u2019ili\u2019ili i Amerika Samoa","volume":"50","author":"V Tofaeono","year":"2020","journal-title":"The British Journal of Social Work"},{"issue":"1","key":"pntd.0011347.ref059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-6-218","article-title":"A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands","volume":"6","author":"H Harrington","year":"2013","journal-title":"Parasites & vectors"},{"key":"pntd.0011347.ref060","first-page":"80","article-title":"Unlocking trust in community health systems: lessons from the lymphatic filariasis morbidity management and disability prevention pilot project in Luangwa District, Zambia","volume":"11","author":"JM Zulu","year":"2022","journal-title":"International Journal of Health Policy and Management"},{"issue":"Supplement_5","key":"pntd.0011347.ref061","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.1093\/infdis\/jiz647","article-title":"Elimination or resurgence: modelling lymphatic filariasis after reaching the 1% microfilaremia prevalence threshold","volume":"221","author":"JM Prada","year":"2020","journal-title":"The Journal of infectious diseases"},{"issue":"10","key":"pntd.0011347.ref062","doi-asserted-by":"crossref","first-page":"e0008644","DOI":"10.1371\/journal.pntd.0008644","article-title":"Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)","volume":"14","author":"BS Collyer","year":"2020","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0011347.ref063","article-title":"The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling","volume":"3","author":"Group NMCLF","year":"2019","journal-title":"Gates open research"},{"issue":"4","key":"pntd.0011347.ref064","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4269\/ajtmh.2007.77.593","article-title":"A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of lymphatic filariasis","volume":"77","author":"HA Farid","year":"2007","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"pntd.0011347.ref065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.epidem.2017.02.002","article-title":"Measuring and modelling the effects of systematic non-adherence to mass drug administration","volume":"18","author":"L Dyson","year":"2017","journal-title":"Epidemics"},{"issue":"4","key":"pntd.0011347.ref066","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1473-3099(16)30467-4","article-title":"Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study","volume":"17","author":"MA Irvine","year":"2017","journal-title":"The Lancet Infectious Diseases"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011347","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:11:13Z","timestamp":1685556673000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011347"}},"subtitle":[],"editor":[{"given":"Mar\u00eda-Gloria","family":"Bas\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011347","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011347","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}